Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 2Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 7Leukemia 7Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, Mantle-Cell 4Hodgkin Disease 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Immunoblastic Lymphadenopathy 3Hematologic Neoplasms 3Burkitt Lymphoma 3Recurrence 2Primary Myelofibrosis 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Blast Crisis 2Thrombocytosis 1

Interventions

fludarabine phosphate 27Peripheral Blood Stem Cell Transplantation 25Cyclophosphamide 24Busulfan 17Tacrolimus 16Whole-Body Irradiation 15Mycophenolic Acid 14Methotrexate 12Cyclosporine 12Antilymphocyte Serum 10Melphalan 7Filgrastim 7Etoposide 7fludarabine 6Radiotherapy 5Decitabine 5Carboplatin 5ruxolitinib 4Topotecan 4Methylprednisolone 4Flow Cytometry 4Cytarabine 4Thiotepa 3Imatinib Mesylate 3Cytogenetic Analysis 3Alemtuzumab 3veliparib 2merphos 2liposomal amphotericin B 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycythemia Vera × Panobinostat × Other hematologic neoplasm × Clear all
NCT02386800 2026-05-27

CINC424A2X01B Rollover Protocol

Novartis

Phase 4 Active not recruiting
279 enrolled
MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡